Literature DB >> 26958726

Human Cytomegalovirus: Coordinating Cellular Stress, Signaling, and Metabolic Pathways.

Thomas Shenk1, James C Alwine2.   

Abstract

Viruses face a multitude of challenges when they infect a host cell. Cells have evolved innate defenses to protect against pathogens, and an infecting virus may induce a stress response that antagonizes viral replication. Further, the metabolic, oxidative, and cell cycle state may not be conducive to the viral infection. But viruses are fabulous manipulators, inducing host cells to use their own characteristic mechanisms and pathways to provide what the virus needs. This article centers on the manipulation of host cell metabolism by human cytomegalovirus (HCMV). We review the features of the metabolic program instituted by the virus, discuss the mechanisms underlying these dramatic metabolic changes, and consider how the altered program creates a synthetic milieu that favors efficient HCMV replication and spread.

Entities:  

Keywords:  AMPK; glutaminolysis; glycolysis; host-virus interactions; mTOR; unfolded protein response

Year:  2014        PMID: 26958726     DOI: 10.1146/annurev-virology-031413-085425

Source DB:  PubMed          Journal:  Annu Rev Virol        ISSN: 2327-056X            Impact factor:   10.431


  30 in total

1.  Human Cytomegalovirus Induces the Expression of the AMPKa2 Subunit to Drive Glycolytic Activation and Support Productive Viral Infection.

Authors:  Diana M Dunn; Irene Rodriguez-Sanchez; Xenia Schafer; Joshua Munger
Journal:  J Virol       Date:  2020-12-02       Impact factor: 5.103

2.  Advances in the Development of Therapeutics for Cytomegalovirus Infections.

Authors:  Edward Acosta; Terry Bowlin; Jennifer Brooks; Lillian Chiang; Islam Hussein; David Kimberlin; Lawrence M Kauvar; Randi Leavitt; Mark Prichard; Richard Whitley
Journal:  J Infect Dis       Date:  2020-03-05       Impact factor: 5.226

3.  P2Y2 purinergic receptor modulates virus yield, calcium homeostasis, and cell motility in human cytomegalovirus-infected cells.

Authors:  Saisai Chen; Thomas Shenk; Maciej T Nogalski
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-03       Impact factor: 11.205

4.  Cellular responses to human cytomegalovirus infection: Induction of a mesenchymal-to-epithelial transition (MET) phenotype.

Authors:  Adam Oberstein; Thomas Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-05       Impact factor: 11.205

5.  Aberrant regulation of the Akt signaling network by human cytomegalovirus allows for targeting of infected monocytes.

Authors:  Megan A Peppenelli; Michael J Miller; Aaron M Altman; Olesea Cojohari; Gary C Chan
Journal:  Antiviral Res       Date:  2018-07-25       Impact factor: 5.970

6.  Human Cytomegalovirus pUL37x1 Is Important for Remodeling of Host Lipid Metabolism.

Authors:  Yuecheng Xi; Samuel Harwood; Lisa M Wise; John G Purdy
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

7.  Kinome Profiling Identifies Druggable Targets for Novel Human Cytomegalovirus (HCMV) Antivirals.

Authors:  Kyle C Arend; Erik M Lenarcic; Heather A Vincent; Naim Rashid; Eric Lazear; Ian M McDonald; Thomas S K Gilbert; Michael P East; Laura E Herring; Gary L Johnson; Lee M Graves; Nathaniel J Moorman
Journal:  Mol Cell Proteomics       Date:  2017-02-25       Impact factor: 5.911

8.  Remodeling mTORC1 Responsiveness to Amino Acids by the Herpes Simplex Virus UL46 and Us3 Gene Products Supports Replication during Nutrient Insufficiency.

Authors:  Elizabeth I Vink; Sora Lee; James R Smiley; Ian Mohr
Journal:  J Virol       Date:  2018-11-27       Impact factor: 5.103

9.  The Clinically Approved Antifungal Drug Posaconazole Inhibits Human Cytomegalovirus Replication.

Authors:  Beatrice Mercorelli; Anna Luganini; Marta Celegato; Giorgio Palù; Giorgio Gribaudo; Galina I Lepesheva; Arianna Loregian
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

10.  Human Cytomegalovirus UL135 Interacts with Host Adaptor Proteins To Regulate Epidermal Growth Factor Receptor and Reactivation from Latency.

Authors:  Michael A Rak; Jason Buehler; Sebastian Zeltzer; Justin Reitsma; Belen Molina; Scott Terhune; Felicia Goodrum
Journal:  J Virol       Date:  2018-09-26       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.